Showing 6721-6730 of 9552 results for "".
- Rhode Island Takes Steps to Increase Sunscreen Access for Childrenhttps://practicaldermatology.com/news/rhode-island-takes-steps-to-increase-sunscreen-access-for-children/2460866/Rhode Island students will now be able to possess and utilize sunscreen at school and school-related activities, thanks to advocacy from the American Society for Dermatologic Surgery Association (ASDSA) and the Rhode Island Dermatology Society. Governor Daniel McKee signed into la
- Sunscreen Recall: J & J Pulls Five Sunscreens Due to Benzene Contaminationhttps://practicaldermatology.com/news/sunscreen-recall-j-j-pulls-five-sunscreens-due-to-benzene-contamination/2460865/Johnson & Johnson is recalling five Neutrogena and Aveeno aerosol sunscreens after finding low levels of benzene in some samples. The recalled sunscreen products include: AVEENO PROTECT + REFRESH aerosol sunscreen NEUTROGENA Beach Def
- Amgen, International Federation of Psoriasis Associations Launch UPLIFT Innovation Challengehttps://practicaldermatology.com/news/amgen-international-federation-of-psoriasis-associations-launch-uplift-innovation-challenge/2460862/Amgen and the International Federation of Psoriasis Associations are launching the
- CeraVe Research Highlights the Impact of UV Exposure on the Skin Barrier and the Benefits of Ceramideshttps://practicaldermatology.com/news/cerave-research-highlights-the-impact-of-uv-exposure-on-the-skin-barrier-and-the-benefits-of-ceramides/2460859/A skincare regimen that includes a moisturizer and sunscreen formulated with ceramides can help protect against ultraviolet(UV)-induced skin barrier damage and improve skin barrier health overall, according to new research in the Journal of Drugs in Dermatology. The clin
- FDA Approves New Cheek Filler from Galdermahttps://practicaldermatology.com/news/fda-approves-new-cheek-filler-from-galderma/2460856/The U.S. Food and Drug Administration (FDA) approved Galderma’s Restylane Contour for cheek augmentation and correction of midface contour deficiencies in adults over the age of 21. Restylane Contour, a new hyaluronic acid (HA) dermal filler, is Galde
- New AKN Classification System May Improve Treatmenthttps://practicaldermatology.com/news/new-akn-classification-system-may-improve-treatment/2460852/A new classification system aims to improve the way that Acne Keloidalis Nuchae or AKN is treated. AKN can begin as tiny bumps on the back of the head, typically following a close haircut. However, due to a patient's genetic predisposition, these lesions become unremitt
- Chicago Area Shade Structures to be Dedicatedhttps://practicaldermatology.com/news/chicago-area-shade-structures-to-be-dedicated/2460844/The Deerfield Park District on Monday dedicates Shade Structures installed at Jewett Park Preschool Playground. Len Kasper, the radio play-by-play announcer for the Chicago White Sox, leads the dedication and will share his personal messa
- Research Brief: Personalized Bacteriotherapy May Improve Skin Microbiome and Symptoms in ADhttps://practicaldermatology.com/news/research-brief-personalized-bacteriotherapy-may-improve-skin-microbiome-and-symptoms-in-ad/2460841/Bacteriotherapy with an autologous strain of bacteria may safely improve S. aureus colonization in the microbiome of patients with atopic dermatitis (AD) and improve disease severity, a
- FDA Approves StrataGraft for the Treatment of Adults with Thermal Burnshttps://practicaldermatology.com/news/fda-approves-stratagraft-for-the-treatment-of-adults-with-thermal-burns/2460839/The U.S. Food and Drug Administration approved StrataGraft for the treatment of adult deep partial thickness burns. "Serious burns can be an incredibly difficult injury to treat and can adversely affect more than just the skin. The goal of burn management is to help the patient ret
- FDA Grants Breakthrough Device Status to Alpha DaRT for SCChttps://practicaldermatology.com/news/fda-grants-breakthrough-device-status-to-alpha-dart-for-scc/2460829/The U.S. Food and Drug Administration (FDA) granted Alpha Tau Medical a Breakthrough Device Designation for Alpha DaRT for the treatment of squamous cell carcinoma (SCC) of the skin and oral cavity without curative standard of care. Alpha Tau submitted data to the FDA supporting this de